SynthesisFrontiers in physiology2026
Effectiveness of non-pharmacological therapies in complementary and alternative medicine on improving fatigue levels, oxidative stress, inflammation, and endocrine levels in animal models of chronic fatigue-like conditions: a systematic review and network meta-analysis.
Synthesis in Frontiers in physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To systematically evaluate the effects of various complementary and alternative medicine (CAM) non-pharmacological therapies on fatigue levels, oxidative stress, inflammation, and endocrine indicators in chronic fatigue-like conditions animal models, and to rank the efficacy of these interventions. Methods: A computerized search was conducted across databases including PubMed, Cochrane Library, Embase, Web of Science, CNKI, Wanfang, VIP, and CBMdisc, to collect animal experiments on fatigue-like conditions treated with CAM non-pharmacological therapies published from the establishment of the databases to January 14, 2026. Two researchers independently screened the literature, extracted data, and assessed risk of bias. Stata 16.0 software was used for network meta-analysis, and SYRCLE's risk of bias tool was employed to evaluate the quality of the included studies. Results: A total of 77 studies involving nine types of CAM non-pharmacological therapies were included. In terms of improving fatigue levels, compared to the control group, electroacupuncture (MD = 347.00 s, 95% CI [144.70, 549.29]) and moxibustion (MD = 311.28 s, 95% CI [146.36, 476.20]) significantly prolonged exhaustive swimming time. In terms of improving oxidative stress damage, fire acupuncture (MD = -13.15 nmol/ml, 95% CI [-18.06, -8.24]), manual acupuncture (MD = -3.85 nmol/ml, 95% CI [-5.12, -2.58]), needle-pricking (MD = -11.43 nmol/ml, 95% CI [-16.54, -6.32]), and moxibustion (MD = -479.16 nmol/ml, 95% CI [-567.05, -391.27]) significantly reduced MDA levels. In terms of improving inflammatory damage, Tuina (MD = -552.03 pg/ml, 95% CI [-700.81, -403.25]) and electroacupuncture (MD = -156.59 pg/ml, 95% CI [-259.85, -53.34]) can significantly reduce the level of IL-1β. In terms of regulating endocrine, electroacupuncture (MD = -9.91 pg/ml, 95% CI [-14.77, -5.05]) and Tuina (MD = -16.96 pg/ml, 95% CI [-25.37, -8.55]) can significantly reduce the level of CRH. Conclusion: Non-pharmacological therapies in complementary and alternative medicine have great potential in improving fatigue-related phenotypes, oxidative stress damage, inflammatory damage, and regulating endocrine levels in animal models of fatigue-like conditions. Future research should focus on developing animal models that better replicate the pathogenesis and core characteristics of CFS, and then extend them to randomized controlled trials involving CFS patients to verify the transformation potential. Systematic review registration: https://www.crd.york.ac.uk/prospero/, identifier CRD420251177070.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.